Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Salpingectomy (Tubectomy) With Delayed Oophorectomy to Improve Quality of Life as Alternative for Risk Reducing Salpingo-oophorectomy in BRCA1/2 Gene Mutation Carriers

NCT02321228 is registered in ClinicalTrials.gov with University Medical Center Nijmegen as lead sponsor.

NCT NCT02321228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02321228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy to Improve Quality of Life as Alternative for Risk Reducing Salpingo-oophorectomy in BRCA1/2 Gene Mutation Carriers
Lead sponsor
University Medical Center Nijmegen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2015
Completion date
January 31, 2035
Enrollment
510 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 gene mutation, brca2 gene mutation, ovarian cancer